MX2017006679A - Formas cristalinas de inhibidores de poli adp-ribosa polimerasa (parp). - Google Patents
Formas cristalinas de inhibidores de poli adp-ribosa polimerasa (parp).Info
- Publication number
- MX2017006679A MX2017006679A MX2017006679A MX2017006679A MX2017006679A MX 2017006679 A MX2017006679 A MX 2017006679A MX 2017006679 A MX2017006679 A MX 2017006679A MX 2017006679 A MX2017006679 A MX 2017006679A MX 2017006679 A MX2017006679 A MX 2017006679A
- Authority
- MX
- Mexico
- Prior art keywords
- crystalline forms
- parp inhibitors
- forms
- methyl
- cyclopenta
- Prior art date
Links
- 239000012661 PARP inhibitor Substances 0.000 title 1
- 229940121906 Poly ADP ribose polymerase inhibitor Drugs 0.000 title 1
- 239000012458 free base Chemical group 0.000 abstract 1
- 150000003839 salts Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/08—Acetic acid
- C07C53/10—Salts thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/13—Dicarboxylic acids
- C07C57/15—Fumaric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
- C07C59/06—Glycolic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462084652P | 2014-11-26 | 2014-11-26 | |
| PCT/US2015/062572 WO2016086080A1 (en) | 2014-11-26 | 2015-11-25 | Crystalline forms of parp inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2017006679A true MX2017006679A (es) | 2018-07-06 |
Family
ID=54849709
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017006679A MX2017006679A (es) | 2014-11-26 | 2015-11-25 | Formas cristalinas de inhibidores de poli adp-ribosa polimerasa (parp). |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10150772B2 (OSRAM) |
| EP (1) | EP3224259A1 (OSRAM) |
| JP (1) | JP2017535564A (OSRAM) |
| KR (1) | KR20170088894A (OSRAM) |
| CN (1) | CN107207511A (OSRAM) |
| AU (1) | AU2015353549A1 (OSRAM) |
| BR (1) | BR112017010588A2 (OSRAM) |
| CA (1) | CA2967828A1 (OSRAM) |
| HK (1) | HK1244006A1 (OSRAM) |
| IL (1) | IL252162A0 (OSRAM) |
| MX (1) | MX2017006679A (OSRAM) |
| RU (1) | RU2017120655A (OSRAM) |
| WO (1) | WO2016086080A1 (OSRAM) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060276497A1 (en) * | 2000-05-09 | 2006-12-07 | Cephalon, Inc. | Novel multicyclic compounds and the use thereof |
| US7122679B2 (en) | 2000-05-09 | 2006-10-17 | Cephalon, Inc. | Multicyclic compounds and the use thereof |
| DE602007009717D1 (de) * | 2006-11-20 | 2010-11-18 | Cephalon Inc | Verfahren zur strahlensensibilisierung von tumoren mit einem strahlensensibilisierungsmittel |
| ES2572652T3 (es) * | 2009-08-26 | 2016-06-01 | Cephalon, Inc. | Nuevas formas de un compuesto multicíclico |
-
2015
- 2015-11-25 CN CN201580063386.3A patent/CN107207511A/zh active Pending
- 2015-11-25 AU AU2015353549A patent/AU2015353549A1/en not_active Abandoned
- 2015-11-25 JP JP2017527299A patent/JP2017535564A/ja active Pending
- 2015-11-25 RU RU2017120655A patent/RU2017120655A/ru not_active Application Discontinuation
- 2015-11-25 HK HK18103530.1A patent/HK1244006A1/zh unknown
- 2015-11-25 KR KR1020177016523A patent/KR20170088894A/ko not_active Withdrawn
- 2015-11-25 CA CA2967828A patent/CA2967828A1/en not_active Abandoned
- 2015-11-25 WO PCT/US2015/062572 patent/WO2016086080A1/en not_active Ceased
- 2015-11-25 EP EP15808507.6A patent/EP3224259A1/en not_active Withdrawn
- 2015-11-25 US US15/529,883 patent/US10150772B2/en not_active Expired - Fee Related
- 2015-11-25 BR BR112017010588-8A patent/BR112017010588A2/pt not_active Application Discontinuation
- 2015-11-25 MX MX2017006679A patent/MX2017006679A/es unknown
-
2017
- 2017-05-08 IL IL252162A patent/IL252162A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL252162A0 (en) | 2017-07-31 |
| BR112017010588A2 (pt) | 2018-05-15 |
| US10150772B2 (en) | 2018-12-11 |
| RU2017120655A3 (OSRAM) | 2018-12-14 |
| CN107207511A (zh) | 2017-09-26 |
| KR20170088894A (ko) | 2017-08-02 |
| WO2016086080A1 (en) | 2016-06-02 |
| CA2967828A1 (en) | 2016-06-02 |
| AU2015353549A1 (en) | 2017-06-01 |
| EP3224259A1 (en) | 2017-10-04 |
| RU2017120655A (ru) | 2018-12-14 |
| US20170267683A1 (en) | 2017-09-21 |
| JP2017535564A (ja) | 2017-11-30 |
| HK1244006A1 (zh) | 2018-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SMT202300273T1 (it) | Derivati di tieno[2,3–d]pirimidina sostituiti come inibitori di menina–mll e metodi d’uso | |
| IL254224A0 (en) | 7-substituted 5-alkyl-[4,2,1]triazolo[5,1-a]pyrimidine derivatives as pde2 inhibitors | |
| NZ727601A (en) | Dihydropyrimido fused ring derivative as hbv inhibitor | |
| NZ716392A (en) | Fused tricyclic urea compounds as raf kinase and/or raf kinase dimer inhibitors | |
| ZA201505944B (en) | New octahydro-pyrrolo[3,4-c]-pyrrole derivatives and analogs thereof as autotaxin inhibitors | |
| NZ739876A (en) | Process for preparing parp inhibitor, crystalline forms, and uses thereof | |
| ZA201607736B (en) | Analogs of 4h-pyrazolo[1,5-a]benzimidazole compounds as parp inhibitors | |
| PH12016501232A1 (en) | Pyrazolo[1,5-a]pyridine derivatives and methods of their use | |
| HRP20171724T1 (hr) | Imidazo[1,2-b]piridazin derivati kao inhibitori kinaze | |
| IL266305B (en) | History of [4,2,1]triazolo[5,1-a]pyrimidine as pde2 inhibitors | |
| MY191628A (en) | Novel triazolo[4,5-d]pyrimidine derivatives | |
| JOP20140141B1 (ar) | استخدام 3،2- ثنائي هيدروإيميدازول-[2،1-c] كونازولينات مستبدلة لمعالجة الاورام الليمفاوية | |
| MX341456B (es) | Amino-quinolinas como inhibidores de cinasa. | |
| IL269214B (en) | Novel imidazo[5,4-c]quinoline derivatives as lrrk2 inhibitors | |
| IL290419A (en) | Imidazo[a-1,5]pyrazine derivatives as inhibitors of pi3k delta | |
| EP3196199A4 (en) | Substituted n-(pyrrolidine-3-yl)-7h-pyrrolo[2,3-d]pyrimidine-4-amine as janus kinase inhibitor | |
| MX2016002176A (es) | Azaindoles enriquecidos isotopicamente. | |
| TN2017000065A1 (en) | A tetrahydropyrrolo[3,4-d][1,3]thiazine-derivative as bace inhibitor | |
| MX2019006956A (es) | Proceso para la fabricacion de derivados de diazepina. | |
| IN2013MU03468A (OSRAM) | ||
| UA86581U (en) | 2-AMINO-4-METHYL-9-(3,4-DIMETHOXYPHENYL)-7- OXO-3-CYANO-6,7,8,9-TETRAHYDROPYRIDO[3',2':4,5]THIENO[3,2-b]PYRIDINE | |
| UA106812U (uk) | 3Н-ТІАЗОЛО[4,3-b]ХІНАЗОЛІН-1,9-ДІОН, ЩО ПРОЯВЛЯЄ АНТИЕКСУДАТИВНУ ДІЮ | |
| IN2013CH03945A (OSRAM) | ||
| LV14663A (lv) | Pirolo[1,2-a]hinazolīna atvasinājumu sintēze no N-antranilskābes hidrazīdiem un alfa-ketoskābēm | |
| UA89443U (en) | 2-(6,8-dimethyl-[1,2,4]triazolo[4,3-b] pyridazine-3-yl- sulphonyl)-1- phenothiazin -10-yl-ethanone exhibiting anticonvulsant activity |